跳至主要内容
临床试验/NCT04810949
NCT04810949终止不适用

Effect of Vitamin D Supplementation on the Development of Respiratory Infections (COVID-19) in Health Personnel at Hospital Clínica NOVA With Serum Values> 20ng / ml

Hospital Clinica Nova2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2020年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
41
试验地点
2
主要终点
Number of participants with Influenza A infection with Vitamin D3 > 20ng/ml

研究概览

简要总结

Scarce information exists in relation to the effect of supplementation of Vitamin D3 in SARS-COV-2 infection, H1N1, and A, B Influenza when 25-hydroxyvitamin levels are between 20-100ng/ml. This study will evaluate the effect of supplementation of vitamin D3 vs. dietary-hygiene measures in SARS-COV-2 , H1N1, A, B Influenza infection rate in patients with serum 25-hydroxyvitamin D3 levels >20ng/ml.

A comparative randomized study that will evaluate the effect of a monthly supplementation with 52000 units of Vitamine D3 during three months vs hygienic-dietary measures in the development of respiratory infections such as COVID-19, H1N1, A, B Influenza during 6 months of follow-up in health workers from a hospital in Northern Mexico with serum vitamin D values +/- 20ng/ml. Also, patients that during screening have 25-hydroxyvitamin D3 levels <20 ng/ml will receive vitamin D supplementation according to primary care discretion for three months and will be followed for 6 months and infection rate will be analyzed and compared.

详细描述

COVID-19 is an infectious disease caused by the newly discovered coronavirus SARS-CoV-2, with a clinical spectrum from asymptomatic infection to critical and fatal illnesses. Influenza H1N1, A, and B have also been the most frequent etiologies of respiratory tract infection that are usually affected during the winter season before COVID-19 pandemic.

There is controversy against Vitamin D3 supplementation in the prevention of respiratory tract infections. A previous meta-analysis has demonstrated an association between vitamin D3 levels <20mg/dl and a higher risk of infection. There is less information in relation to the effect of supplementation when vitamin levels are between 20-100ng/ml and the prevention of infection.

The rationale of this study will be to find a relationship between vitamin D3 supplementation and the incidence of SARS-CoV-2 or Influenza H1N1, A, or B infection through a prospective study. Vitamin D3 could have a role in innate and adaptive immunity that could help prevent this disease. The target population will be health workers with a high risk of SARS-COV-2 or influenza infection with vitamin D > 20 ng/ml.

The primary aim is to evaluate the effect of vitamin D3 supplementation vs. dietary-hygiene measures in developing SARS-COV-2 infection, Influenza H1N1, A or B in patients with serum 25-hydroxyvitamin D3 >20 ng/ml.

A secondary aim will be to compare a group of hospital workers with serum 25-hydroxyvitamin D3 < 20 ng/ml that could or not have been supplemented with Vitamin D3.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-90 years
  • Both genders
  • Absence of infection by COVID-19, influenza H1N1, influenza A or B at the time of measurement of serum vitamin D levels.
  • Absence of infection at any site of bacterial, fungal or other origins
  • Health worker at Hospital Clínica Nova.

排除标准

  • for both arms:
  • Serum Vitamin D levels> 100ng / ml
  • Previous consumption of supplements containing Vitamin D3
  • Pregnancy

结局指标

主要结局

Number of participants with Influenza A infection with Vitamin D3 > 20ng/ml

时间窗: 6 months

Evaluate the number of patients that get infected by Influenza A with vitamin D3 levels +/- 20ng/ml that receive supplementation or diet or hygiene measures

Number of participants with Influenza H1N1 infection with Vitamin D3 > 20ng/ml

时间窗: 6 months

Evaluate the number of patients that get infected by H1N1 infection with vitamin D3 levels +/- 20ng/ml that receive supplementation or diet or hygiene measures

Number of participants with Covid-19 Infection with Vitamin D3 > 20ng/ml

时间窗: 6 months

Evaluate the number of patients that get infected by COVID-19 during study period with vitamin D3 levels \>20ng/ml that receive supplementation or diet and hygiene measures

Number of participants with Influenza B infection with Vitamin D3 > 20ng/ml

时间窗: 6 months

Evaluate the number of patietns that get infected by Influenza B with vitamin D3 levels +/- 20ng/ml that receive supplementation or diet or hygiene measures

次要结局

  • Number of participants with influenza A Infection with Vitamin D3 < 20ng/ml(6 months)
  • Number of participants with H1N1 infection Infection with Vitamin D3 < 20ng/ml(6 months)
  • Number of participants with Covid-19 Infection with Vitamin D3 < 20ng/ml(6 months)
  • Number of participants with influenza B Infection with Vitamin D3 < 20ng/ml(6 months)

研究者

发起方
Hospital Clinica Nova
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Elena Romero Ibarguengoitia

Principal Investigator/Research Director

Hospital Clinica Nova

研究点 (2)

Loading locations...

相似试验